Penile rehabilitation following treatment for prostate cancer: An analysis of the current state of the art

Journal of the Canadian Urological Association

Volumn 3, Issue 1, 2009, Pages 37-48

  Shaiji, Tariq Al ^a   Domes, Trustin ^a   Brock, Gerald ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350321168     PISSN: 19116470     EISSN: 19116470     Source Type: Journal    
DOI: 10.5489/cuaj.1014     Document Type: Review

References (84)

1. Meuleman EJ, Mulders PF. Erectile function after radical prostatectomy: a review discussion 101-2]. Eur Urol 2003;43:95-101.
2. Calabrese DA. Prostate cancer in older men. Urol inurs 2004; 24: 258-264
3. Nakamura K, Kasraeian A, Anai S, et al. Positive surgical margins at radical prostatectomy: mportance of intraoperative bladder ineck frozen sections. Int Braz J Urol 2007; 3:746-751
4. Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology ind prevention. J Urol 1982;128:492-497
5. Albersen M, Joniau S, Claes H, et al. Preclinical evidence for the benefits of penile rehabilitation herapy following inerve sparing radical prostatectomy. Adv Urol 2008; 594868.
6. Chuang MS, O'Connor RC, Laven BA, et al. Early release of the ineurovascular bundles ind optical loupe magnification lead to improved and earlier return of potency following radical retropubic prostatectomy. J Urol 2005;173:537-539
7. Masterson TA, Serio AM, Mulhall JP, et al. Modified technique for ineurovascular bundle reservation during radical prostatectomy: association between technique and recovery of erectile function. BJU Int 2008;101:1217-1222
8. Nandipati KC, Raina R, Agarwal A, et al. Erectile dysfunction following radical retropubic prostatectomy: epidemiology, pathophysiology and pharmacological management. rugs Aging 2006;23:101-117
9. Mulhall JP, Morgentaler A. Penile rehabilitation should become the norm for radical prostatectomy patients. J Sex Med 2007;4:538-543
10. Penson D, Moul J, Gandhi S, et al. Use of prostate-specific antigen in the follow-up of patients with localized prostate cancer: results of a inationwide survey of urologists. Urology 2006;68:80-84
11. Kendirci M, Tanriverdi O, Trost L, et al. Management of sildenafil treatment failures. Curr Opin Urol 2006;16:449-459
12. McCullough AR. Prevention and management of erectile dysfunction following radical prostatectomy. Urol Clin north Am 2001;28:613-627
13. Raina R, Lakin MM, Agarwal A, et al. Efficacy and factors associated with successful utcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy. Urology 2004;63:960-966
14. Montorsi F, Briganti A, Salonia A, et al. Current and future strategies for preventing and anaging erectile dysfunction following radical prostatectomy. Eur Urol 2004;45:123-133
15. Burnett AL. Rationale for cavernous inerve restorative therapy to preserve erectile function after radical prostatectomy: results from CaPSURE. J Urol 2004;171:703-708
16. Kury P, Stoll G, Muller HW. Molecular mechanisms of cellular interactions in peripheral erve regeneration. Curr Opin ineurol 2001;14:635-639
17. User HM, Hairston JH, Zelner DJ, et al. Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 2003;169:1175-1179
18. Carrier S, Zvara P, inunes L, et al. Regeneration of initric oxide synthase-containing inerves after cavernous inerve ineurotomy in the rat. J Urol 1995;153:1722-1727
19. Bannowsky A, Schulze H, van der Horst C, et al. nocturnal tumescence: a parameter or postoperative erectile integrity after inerve sparing radical prostatectomy. J Urol 006;175:2214-2217
20. Kaul S, Bhandari A, Hemal A, et al. Robotic radical prostatectomy with preservation of the prostatic fascia: a feasibility study. Urology 2005;66:1261-1265
21. McCullough AR. Rehabilitation of erectile function following radical prostatectomy. Asian Androl 2008;10:61-74.
22. Gontero P, Kirby R. Early rehabilitation of erectile function after inerve-sparing radical prostatectomy: What is the evidence? BJU Int 2004;93:916-918
23. Mulhall JP, Slovick R, Hotaling J, et al. Erectile dysfunction after radical prostatectomy: emodynamic profiles and their correlation with the recovery of erectile function. Urol 2002;167:1371-1375
24. Mulhall JP, Graydon RJ. The hemodynamics of erectile dysfunction following inerve-sparing adical retropubic prostatectomy. Int J Impot Res 1996;8:91-94
25. Wang R. Penile rehabilitation after radical prostatectomy: Where do we stand and where re we going? J Sex Med 2007;4:1085-1097
26. Podlasek CA, Gonzalez CM, Zelner DJ, et al. Analysis of noS isoform changes in a post radical prostatectomy model of erectile dysfunction. Int J Impot Res 2001;13 Suppl 5):S1-15.
27. McVary KT. Alfuzosin for symptomatic benign prostatic hyperplasia: long-term experience. Urol 2006;175:35-42.
28. Moreland RB, Traish A, McMillin MA, et al. PGE1 suppresses the induction of collagen ynthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth uscle. J Urol 1995;153:826-834
29. Daley JT, Watkins MT, Brown ML, et al. Prostanoid production in rabbit corpus cavernosum. I. Inhibition by oxidative stress. J Urol 1996;156:1169-1173
30. Dall'era JE, Mills JN, Koul HK, et al. Penile rehabilitation after radical prostatectomy: mportant therapy or wishful thinking? Rev Urol 2006;8:209-215
31. Leungwattanakij S, Bivalacqua TJ, Usta MF, et al. Cavernous ineurotomy causes hypoxia ind fibrosis in rat corpus cavernosum. J Androl 2003;24:239-245
32. Saenz de Tejada I, Moroukian P, Tessier J, et al. Trabecular smooth muscle modulates he capacitor function of the penis. Studies on a rabbit model. Am J Physiol 1991; 60:H1590-5.
33. Mulhall JP. Penile length changes after radical prostatectomy. BJU Int 2005;96:472-474
34. Gontero P, Galzerano M, Bartoletti R, et al. New insights into the pathogenesis of penile hortening after radical prostatectomy and the role of postoperative sexual function. Urol 2007;178:602-607
35. Montorsi F, Guazzoni G, Strambi LF, et al. Recovery of spontaneous erectile function after inerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol 997;158:1408-1410
36. Goldstein AM, Meehan JP, Zakhary R, et al. New observations on microarchitecture of corpora cavernosa in man and possible relationship to mechanism of erection. Urology 982;20:259-266
37. Iacono F, Giannella R, Somma P, et al. Histological alterations in cavernous tissue after adical prostatectomy. J Urol 2005;173:1673-1676
38. Nehra A, Azadzoi KM, Moreland RB, et al. Cavernosal expandability is an erectile tissue echanical property which predicts trabecular histology in an animal model of asculogenic erectile dysfunction. J Urol 1998;159:2229-2236
39. Ruiz Rubio JL, Hernandez M, Rivera de los Arcos L, et al. Mechanisms of prostaglandin 1-induced relaxation in penile resistance arteries. J Urol 2004;171:968-973 (Pubitemid 38090543)
40. Brock G, Tu LM, Linet OI. Return of spontaneous erection during long-term intracavernosal lprostadil (Caverject) treatment. Urology 2001;57:536-541
41. Dennis RL, McDougal WS. Pharmacological treatment of erectile dysfunction after adical prostatectomy. J Urol 1988;139:775-776
42. Zippe CD, Pahlajani G. Penile rehabilitation following radical prostatectomy: role of early intervention and chronic therapy. [viii.]. Urol Clin north Am 2007;34:601-618 (Pubitemid 350029952)
43. Raina R, Lakin MM, Thukral M, et al. Long-term efficacy and compliance of intracor- oreal (IC) injection for erectile dysfunction following radical prostatectomy: SHIM (IIEF- ) analysis. Int J Impot Res 2003;15:318-322
44. Lakin MM, Montague DK, VanderBrug Medendorp S, et al. Intracavernous injection therapy: Analysis of results and complications. J Urol 1990;143:1138-1141
45. Kava BR. Advances in the management of post-radical prostatectomy erectile dysfunction: treatment strategies when PDE-5 inhibitors don't work. Rev Urol 2005;7(Suppl 2): 39-50.
46. Mulhall J, Land S, Parker M, et al. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. discussion 540-2]. J Sex Med 2005;2:532-540
47. Gontero P, Fontana F, Bagnasacco A, et al. Is there an optimal time for intracavernous rostaglandin E1 rehabilitation following nonnerve sparing radical prostatectomy? esults from a hemodynamic prospective study. J Urol 2003;169:2166-2169
48. Nandipati K, Raina R, Agarwal A, et al. Early combination therapy: intracavernosal injections ind sildenafil following radical prostatectomy increases sexual activity and the eturn of inatural erections. Int J Impot Res 2006;18:446-451
49. Bechara A, Casabe A, Cheliz G, et al. Prostaglandin E1 versus mixture of prostaglandin 1, papaverine and phentolamine in non-responders to high papaverine plus phentolamine oses. J Urol 1996;155:913-914
50. Baniel J, Israilov S, Segenreich E, et al. Comparative evaluation of treatments for rectile dysfunction in patients with prostate cancer after radical retropubic prostatectomy. JU Int 2001;88:58-62.
51. Padmanaban P, McCullough AR. The effect of prostaglandin E-1(PGE-1) urethral suppository MUSETM) and injections on corporal oxygen saturation (StO2) in men with rectile dysfunction (ED) [abstract]. American Society of Andrology Meeting 2006, pr. 8-11, Chicago. J Androl 2006;27.
52. Porst H. Transurethral alprostadil with MUSE (Medicated Urethral System for Erection) . intracavernous alprostadil - a comparative study in 103 patients with erectile ysfunction. Int J Impot Res 1997;9:187-192
53. Lepor H, McCullough A. Penile rehabilitation post-prostatectomy: Is there a role for USE? Rev Urol 2008;10:1-5.
54. Costabile RA, Spevak M, Fishman IJ, et al. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy. J Urol 1998;160: 325-328
55. McCullough A. The effect of low dose intraurethral alprostadil (MUSE®) on corporal xygenation after inerve sparing radical prostatectomy. [Abstract 77]. J Sex Med 2007; (suppl 1):89.
56. Raina R, Pahlajani G, Agarwal A, et al. The early use of transurethral alprostadil after adical prostatectomy potentially facilitates an earlier return of erectile function and successful exual activity. BJU Int 2007;100:1317-1321
57. Sidi AA, Becher EF, Zhang G, et al. Patient acceptance of and satisfaction with an external egative pressure device for impotence. J Urol 1990;144:1154-1156
58. Bosshardt RJ, Farwerk R, Sikora R, et al. Objective measurement of the effectiveness, herapeutic success and dynamic mechanisms of the vacuum device. Br J Urol 995;75:786-791
59. Kohler TS, Pedro R, Hendlin K, et al. A pilot study on the early use of the vacuum rection device after radical retropubic prostatectomy. BJU Int 2007;100:858-862
60. Raina R, Agarwal A, Ausmundson S, et al. Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier eturn of erectile function. Int J Impot Res 2006;18:77-81.
61. Lue TF. Erectile dysfunction. N. Engl J Med 2000;342:1802-1813
62. De Young LX, Domes T, Lim K, et al. Endothelial rehabilitation: the impact of chronic DE5 inhibitors on erectile function and protein alterations in cavernous tissue of diabetic ats. Eur Urol 2008;54:213-220
63. Ahn GJ, Sohn YS, Kang KK, et al. The effect of PDE5 inhibition on the erectile function in streptozotocin-induced diabetic rats. Int J Impot Res 2005;17:134-141
64. Ferrini MG, Kovanecz I, nolazco G, et al. Effects of long-term vardenafil treatment in the development of fibrotic plaques in a rat model of Peyronie's disease. BJU Int 006;97:625-633
65. Ferrini MG, Davila HH, Kovanecz I, et al. Vardenafil prevents fibrosis and loss of corporal mooth muscle that occurs after bilateral cavernosal inerve resection in the rat. Urology 2006;68:429-435
66. Vignozzi L, Filippi S, Morelli A, et al. Effect of chronic tadalafil administration on penile ypoxia induced by cavernous ineurotomy in the rat. J Sex Med 2006;3:419-431
67. Kovanecz I, Rambhatla A, Ferrini M, et al. Long-term continuous sildenafil treatment meliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal inerve esection in rats. Int J Impot Res 2008;20:202-212
68. Schwartz EJ, Wong P, Graydon RJ. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 2004;171:771-774
69. McCullough AR, Levine LA, Padma-Nathan H. Return of nocturnal erections and erectile function after bilateral inerve-sparing radical prostatectomy in men treated inightly ith sildenafil citrate: subanalysis of a longitudinal randomized double-blind placebocontrolled rial. J Sex Med 2008;5:476-484
70. Montorsi F, Maga T, Strambi LF, et al. Sildenafil taken at bedtime significantly increases octurnal erections: results of a placebo-controlled study. Urology 2000;56:906-911
71. Bannowsky A, Schulze H, van der Horst C, et al. Recovery of erectile function after erve-sparing radical prostatectomy: improvement with inightly low-dose sildenafil. BJU int 2008;101:1279-1283
72. Padma-Nathan HMA, Guiliano F, Toler SMWC, et al. Postoperative inightly administration of sildenafil citrate significantly improves the return of normal spontaneous erectile function after bilateral inerve-sparing radical prostatectomy. [Abstract 1402]. J Urol 003;169(suppl):375.
73. Padma-Nathan H, McCullough AR, Levine LA, et al. Randomized, double-blind, placebo- controlled study of postoperative inightly sildenafil citrate for the prevention of erectile dysfunction after bilateral inerve-sparing radical prostatectomy. Int J Impot Res 2008;20:479-486
74. Briganti A, Salonia A, Gallina A, et al. Management of erectile dysfunction after radical prostatectomy in 2007. World J Urol 2007;25:143-148
75. Zumbe J, Porst H, Sommer F, et al. Comparable efficacy of once-daily versus on-demand vardenafil in men with mild-to-moderate erectile dysfunction: findings of the RESTORE study. Eur Urol 2008;54:204-210
76. Montorsi F, Brock G, Lee J, et al. Effect of inightly versus on-demand vardenafil on recovery of erectile function in men following bilateral inerve-sparing radical prostatectomy. Eur Urol 2008;54:924-931
77. Zippe CD, Jhaveri FM, Klein EA, et al. Role of Viagra after radical prostatectomy. Urology 2000;55:241-245
78. Raina R, Lakin MM, Agarwal A, et al. Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up. Urology 2003;62:110-115
79. Feng MI, Huang S, Kaptein J, et al. Effect of sildenafil citrate on post-radical prostatectomy erectile dysfunction. J Urol 2000;164:1935-1938
80. Reece C, Kumar R, inienow D, et al. Extending the rationale of combination therapy to unresponsive erectile dysfunction. Rev Urol 2007;9:197-206.
81. Yassin AAHA, Saad F. Favorable effects of early "penile rehabilitation" following inerve sparing radical prostatectomy. J Sex Med 2006;3(suppl 5):407.
82. Huber NWC, Babaian R, Madsen L, et al. Recovering penile length and erectile function following radical prostatectomy. [Abstract 60]. J Sex Med 2006;3(suppl 1):32.
83. McMahon CG, Samali R, Johnson H. Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy. [discussion 1997-8]. J Urol 1999;162:1992-1997.
84. Nehra A, Blute ML, Barrett DM, et al. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int J Impot Res 2002;14(Suppl 1):S38-42.